Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Chemotherapy of resistant and recurrent lymphoma based on a combination of ifosfamide and etoposide. Antitumor effects, toxicity and stimulation of peripheral stem cells].
Mayer J, Korístek Z, Vásová I, Müllerová I, Král Z, Navrátil M, Klabusay M, Vorlícek J, Vodvárka P, Hejlová N, Penka M, Krahulcová E, Tomíska M, Adam Z, Hájek R. Mayer J, et al. Among authors: penka m. Cas Lek Cesk. 1998 Oct 5;137(19):590-7. Cas Lek Cesk. 1998. PMID: 9818471 Clinical Trial. Czech.
Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-alpha administration.
Hájek R, Zácková D, Büchler T, Penka M, Krahulcová E, Korístek Z, Vinklárková J, Adler J, Janovská E, Indrák K, Faber E, Doubek M, Klabusay M, Oltová A, Kuglík P, Bourková L, Dusek L, Mareschová I, Mayer J, Vorlícek J. Hájek R, et al. Among authors: penka m. Med Oncol. 2003;20(1):69-76. doi: 10.1385/mo:20:1:69. Med Oncol. 2003. PMID: 12665687 Clinical Trial.
[A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review].
Adam Z, Matýková M, Krejcí M, Pour L, Kissová J, Slechtová M, Chlupová G, Stavarová Y, Simonides J, Penka M, Mayer J, Hájek R. Adam Z, et al. Among authors: penka m. Vnitr Lek. 2010 Jan;56(1):67-78. Vnitr Lek. 2010. PMID: 20184115 Review. Czech.
[Comparison of the effectiveness of idarubicin (Zavedos) and mitoxantrone (Refador) in induction therapy of acute myeloid leukemia in elderly patients (55-75) (a prospective multicenter randomized study conducted 1998-2000].
Indrák K, Hubácek J, Mayer J, Voglová J, Jarosová M, Krahulová M, Malý J, Faber E, Penka M, Kmonícek M, Jebavý L, Szotkowski T, Knotková R, Hlusí A, Zapletalová J. Indrák K, et al. Among authors: penka m. Vnitr Lek. 2001 Sep;47 Suppl 1:48-56. Vnitr Lek. 2001. PMID: 11693063 Clinical Trial. Czech.
179 results